Concepedia

Kathrin Schwager

KS

14

Publications

1.3K

Citations

14

H-Index

1998

Active since

Affiliations

ETH Zurich(Current)

Philochem (Switzerland)

Mario Negri Institute for Pharmacological Research

University Hospital of Zurich

Kathrin Schwager is an author at ETH Zurich specializing in oncology, medicine, and tumor biology.

Top concepts

Publications per year

1998–2013

14

Publications

14

Lymphadenopathy: differentiation of benign from malignant disease--color Doppler US assessment of intranodal angioarchitecture.

A. Tschammler, German Ott, T Schang et al. · Radiology · 1998 · 183 citations

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis

Kathrin Schwager, Manuela Kaspar, Frank Bootz et al. · Arthritis Research & Therapy · 2009 · 172 citations · Full text

A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma

Thomas Eigentler, Benjamin Weide, Filippo de Braud et al. · Clinical Cancer Research · 2011 · 149 citations · Full text

A Traceless Vascular‐Targeting Antibody–Drug Conjugate for Cancer Therapy

Gonçalo J. L. Bernardes, Giulio Casi, Sabrina Trüssel et al. · Angewandte Chemie International Edition · 2011 · 128 citations

The Immunocytokine L19–IL2 Eradicates Cancer When Used in Combination with CTLA-4 Blockade or with L19-TNF

Kathrin Schwager, Teresa Hemmerle, David Aebischer et al. · Journal of Investigative Dermatology · 2012 · 101 citations · Full text

, , +10

Rows per page

1–5 of 14